Current concepts on the diagnostic use of MIBG in children

Journal of Nuclear Medicine

Volumn 39, Issue 4, 1998, Pages 679-688

  Shulkin, Barry L ^a   Shapiro, Brahm ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE

Author keywords

Children; Metaiodobenzylguanidine; Neuroblastoma; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; BUTYROPHENONE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; DOBUTAMINE; DOPAMINE; GALLIUM 67; LABETALOL; MAPROTILINE; METARAMINOL; PHENOTHIAZINE DERIVATIVE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; RESERPINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADRENAL MEDULLA TUMOR; CHILDHOOD CANCER; DIAGNOSTIC VALUE; DOSIMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; NEUROBLASTOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RADIOIODINATION; RADIOISOTOPE DISTRIBUTION; REVIEW; TREATMENT INDICATION;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; IODINE RADIOISOTOPES; NEUROBLASTOMA; PHEOCHROMOCYTOMA; RADIATION DOSAGE; RADIOPHARMACEUTICALS;

EID: 0031949131     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. 131I-labeled antiadrenergic agent. J Nucl Med 1980;20:155-158.
2. Sisson JC, Frager MS, Valk TW, et al. Scintigraphic localization of pheochromocytoma. N Engl J Med 1981;305:12-17.
3. 131I-MIBG. J Nucl Med 1994;35:13N-17N.
4. Berthold F. Overview: biology of neuroblastoma. In: Pochedly C, ed. Neurohlastoma: tumor biology and therapy. Boca Raton, FL: CRC Press; 1990:2-27.
5. McEwan AJ, Shapiro B, Sisson JC, Beierwaltes WH, Ackery DM. Radioiodobenzyguantdine for the scintigraphic location and therapy of adrenergic tumors. Semin Nucl Med 1985;15:132-153.
6. Korn N, Buswink A, Yu T, Carr EA, Caroll M, Counsell RE. A radioiodinated bretylium analog as a potential agent for scanning the adrenal medulla. J Nucl Med 1977;18:87-89.
7. 131I-iodobenzylguanidine. Lancet 1984;8372:333-334.
8. Geatti O, Shapiro B, Sisson JC, et al. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases. J Nucl Med 1985;26:736-42.
9. 123I-MIBG. Med Pediatr Oncol 1987;15:170-177.
10. 125I-MIBG. Am J Clin Oncol 1996;19:144-148.
11. 124I-MIBG positron emission tomography. Br J Radiology 1992;65:787-91.
12. 18F]fluoro-3-iodobenzylguanidine, a potential MIBG analogue for positron emission tomography. J Med Chem 1994;37: 3655-3662.
13. Clerc J, Mardon K, Galons R, et al. Assessing intratumor distribution and uptake with MBBG versus MIBG imaging and targeting xenografted PC12-pheochromocytoma cell line. J Nucl Med 1995;36:859-866.
14. Valette H, Loc'h C, Mardon K, et al. Bromine-76-metabromobenzylguanidine: a PET radiotracer for mapping sympathetic nerves of the heart. J Nucl Med 1993;34:1739-1744.
15. 211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent. Int J Cancer 1994;57:908-913.
16. 131I-MIBG imaging in children with neuroblastoma [Abstract]. J Nucl Med 1996;37(suppl):35P.
17. Geatti O, Shapiro B, Shulkin B, Hutchinson R, Sisson JC. Gastrointestinal iodine-131-meta-iodobenzylguanidine activity. Am J Physiol Imaging 1988;3:188-191.
18. Jacques S, Tubes MC, Sisson JC, et al. Comparison of the sodium dependence of uptake of meta-iodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol 1984;26:539-546.
19. Smets LA, Loesberg C, Janssen M, Metwally EA, Huiskamp R. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells. Cancer Res 1989;49:2941-2944.
20. Smets LA, Janssen M, Metwally E, Loesberg C. Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells. Biochem Pharmacol 1990;39:1959-1964.
21. Montaldo PG, Raffaghello L, Guarnaccia F, Pistoia V, Garaventa A, Ponzoni M. Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells. Int J Cancer 1996;67:95-100.
22. Khafagi FA, Shapiro B, Fig LM, Mallette S, Sisson JC. Labetalol reduces iodinc-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 1989;30:481-489.
23. Paltiel HJ, Gelfand MJ, Elgazzar AH, et al. Neural crest tumors: iodine-123-MIBG imaging in children. Radiology 1994;190:117-121.
24. Ruffini V, Fisher GA, Shulkin BL, Sisson JC, Shapiro B. Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging. J Nucl Med 1996;37:1464-1468.
25. 131I-MIBG) in man: evaluation by scintigraphy. J Nucl Med 1983;24:672-682.
26. Bonnin F, Lumbroso J, Tenenbaum F. Hartmann O, Parmentier C, Refining interpretation of MIBG scans in children. J Nucl Med 1994;35:803-810.
27. Hattner RS, Pounds TR, Matthay KK. Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans. Clin Nucl Med 1994;19:985-988.
28. Shulkin BL, Shen SW, Sisson JC, Shapiro B. Iodine-131-MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma. J Nucl Med 1987; 28:315-318.
29. Shapiro B, Shulkin BL, Hutchinson RJ, Bass JC, Gross MD, Sisson JC. Locating neuroblastoma in the opsoclonus-myoclonus syndrome. J Nucl Med Biol 1994;38:545-555.
30. Parisi MT, Hattner RS, Matthay KK, Berg BO, Sandler ED. Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus. J Nucl Med 1993;34:1922-1926.
31. Suc A, Lumbroso J, Rubie H, et al. Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system. Cancer 1996;77:805-811.
32. 99mTc-MDP scintigraphy. J Nucl Biol Med 1993;37:107-114.
33. Englaro EE, Gelfand MJ, Harris RE, Smith HS. Iodine-131-MIBG imaging after bone marrow transplantation for neuroblastoma. Radiology 1992;182:515-520.
34. Lumbroso JD, Guermazi F, Hartmann O, et al. Meta-iodobenzylguanidine (MIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans. Prog Clin Biol Res 1988;271:689-705.
35. 131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the International Workshop of Pediatric Oncology held in Rome, September 1986. Med Pediatr Oncol 1987; 15:181-187.
36. Heyman S, Evans AE. D'Angio GJ. Iodine-131-metaiodobenzylguanidine: diagnostic use in neuroblastoma patients in relapse. Med Pediatr Oncol 1988;16:337-340.
37. Schmiegelow K, Simes MA, Agertoft L, et al. Radio-iodobenzylguanidine scintigraphy of neuroblastoma: conflicting results, when compared with standard investigations. Med Pediatr Oncol 1989;17:127-130.
38. 131I-MIBG) scintigraphy in neuroblastoma: a review of 160 studies. J Nucl Med Allied Sci 1990;34:279-288.
39. Shulkin BL, Shapiro B. Radioiodinated MIBG in the management of neuroblastoma. In: Poehedly C, ed. Neuroblastoma tumor biology and therapy. Boca Raton, FL: CRC Press; 1990:171-198.
40. Andrich MP, Shalaby-Rana E, Movassaghi N, Majd M. The role of iodine-131-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma. Pediatrics 1996;97:246-250.
41. 131I-MIBG for imaging of neuroblastoma [Abstract]. Eur J Nucl Med 1992;19:589.
42. Gelfand MJ, Elgazzar AH, Kriss VM, Masters P, Golsch GJ. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med 1994;35:1753-1757.
43. Shulkin BL, Shapiro B, Hutchinson RJ. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma. J Nucl Med 1992;33:1735-1740.
44. Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. Skeletal assessment in neuroblastoma - the pitfalls of iodine-123-MIBG scans. J Nucl Med 1990;31:129-134.
45. Hadj-Djilani NL, Lebtahi NE, Delaloye AB, Laurini R, Beck D. Diagnosis and follow-up of neuroblastoma by means of iodine-123-metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology. Eur J Nucl Med 1995;22:322-329.
46. Osmanagaoglu K, Lippens M, Benoit Y, Obrie E, Schelstraete K, Simons M. A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma. Eur J Nucl Med 1993;20:1154-1160.
47. Corbett R, Olliff J, Fairley N, et al. A prospective comparison between magnetic resonance imaging, meta-iodobenzylguanidine scintigraphy and marrow histology/ cytology in neuroblastoma. Eur J Cancer 1991;27:1560-1564.
48. Giammarile F, Lumbroso J, Ricard M, et al. Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection. Eur J Nucl Med 1995;22:1180-1183.
49. Leung A, Shapiro B, Hattner R, et al. The specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med 1997;38:1352-1357.
50. Khafagi F, Shapiro B, Fischer M, et al. Pheochromocytomas and functioning paraganglioma in childhood and adolescence: role of iodine-131-metaiodobenzylguandine. Eur J Nucl Med 1991;18:191-198.
51. 123I]iodomethylguanidine: concise communication. J Nucl Med 1984;25:436-440.
52. 123I-metaiodobenzylguanidine. J Nucl Med 1986;27:1138-1142.
53. Shulkin BL, Wieland DM, Baro ME, et al. PET hydroxyephedrine imaging of neuroblastoma. J Nucl Med 1996;37:16-21.
54. Shulkin BL, Wieland DM, Shapiro B, Sisson JC. PET epinephrine studies of pheochromocytoma [Abstract]. J Nucl Med 1995:36(suppl):22P-23P.
55. 67Ga-citrate studies. Clin Nucl Med 1989;14: 515-522.
56. Howman-Giles R, Uren RF, Shaw PJ. Thallium-201 scintigraphy in pediatric soft-tissue tumors. J Nucl Med 1995;36:1372-1376.
57. Sautter-Bihl ML, Dorr U, Schilling F, Treuner J, Bihl H. Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma. Semin Oncol 1994;21(suppl 13):38-41.
58. Manil L, Edeline V, Lumbroso J, Lequen H, Zucker JM. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors. J Nucl Med 1996;37:893-896.
59. 111In DTPA-octreotide. Clin Nucl Med 1995;20:243-249.
60. 18F]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology 1996;199:743-750.
61. Yeh SD, Larson SM, Burch L, et al. Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities. J Nucl Med 1991;32:769-776.
62. Berthold F, Waters W, Sieverts H, Linden A. Immunoscintigraphic imaging of MIBG-negative metastases in neuroblastoma. Am J Pediatr Hematol Oncol 1990;12: 61-62.
63. 123I-labeled monoclonal antibody, UJ13A, against neural tissue. Br J Radiol 1985;58:476-480.
64. Handgretinger R, Anderson K, Lang P, et al. A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Eur J Cancer 1995;31A:261-267.
65. Swanson DP, Carey JE, Brown LE, et al. Human absorbed dose calculations for iodine-131 and iodine-123-labeled meta-iodobenzylguanidine (MIBG): a potent myocardial and adrenal medulla imaging agent. In: Proceedings of the Third International Symposium of Radiopharmaceutical Dosimetry. Oak Ridge, TN: Oak Ridge Associated Universities; 1981:213-224.
66. Shapiro B. MIBG in the Diagnosis and Therapy of Neuroblastoma and Pheochromocytoma. Proceedings of the International Symposium on Recent Advances in Nuclear Medicine; 1987:11-20.
67. Hoefnagel CA, Voute PA, DeKraker J, et al. Radionuclide diagnosis and therapy of neural crest tumors using iodine-131-metaiodobenzyl-guanidine. J Nucl Med 1987;28: 308-314.
68. 123I labelled metaiodobenzyl-guanidine [Abstract]. Eur J Nucl Med 1985;11:A16.
69. Heyman S, Evans AE. Iodine-131-metaiodobenzylguanidine (I-131-MIBG) in the diagnosis of neuroblastoma [Abstract]. J Nucl Med 1986;27:931.
70. Munkner T. Scintigraphy of neuroblastoma. Nuklearmedizin 1986(suppl):436-438.
71. Feine U, Treuner J, Niethammer D, et al. Erste untenshungen zur scintigraphischen darstellung von neuroblastomen mit 131-J-meta-benzylguanidin. Nuc Compact 1984; 15:23-26.
72. Fischer M, Galanski M, Winterberg B, Vene H. Localization procedures in pheochromocytoma and neuroblastoma. Cardiology 1985;72(suppl 1):143-146.
73. Edeling CJ, Buchler Frederiksen P, Kamper J, Jeppesen R. Diagnosis and treatment of neuroblastoma using metaiodobenzylguanidine. Clin Nucl Med 1987;8:632-637.
74. Muller-Gartner HW, Erttmann R, Helmke K. Die Szintigraphie mit Radiojod-[Meta-Jod-Benzylguanidin] in der Diagnostik des Neuroblastoms. Nuklearmedizin 1985;24: 222-226.
75. Kimmig B, Brandeis WE, Eisenhut M, Ludwig R, Adolph J. Szintigraphische Diagnostik des Neuroblastoms mit meta-Jod-Benzylguanidin. Klin Padiat 1986;198: 224-229.
76. Odano I. Masayuki T, Saka K. Significance of I-131 meta-iodobenzylguanidine scintigraphy in diagnosing neuroblastoma. Kaku Igaku 1986;11:1685-1688.
77. Caballero O, Ferris J, Verdeguer A, Esquembre C, Castel V. Iodine-131 metaiodobenzylguanidine. J Nucl Med 1986;27:868-869.
78. Hadley GP, Rabe E. Scanning with iodine-131-MIBG in children with solid tumors: an initial appraisal. J Nucl Med 1986;27:620-626.
79. 131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the International Workshop of Pediatric Oncology Held in Rome, September 1986. Med Pediatr Oncol 1987;15:181-187.